Lamisil

Terbinafine, the active ingredient in Lamisil, is an allylamine antifungal presented as a topical formulation for skin use. It treats fungal infections of the skin and nails in adults and children as directed by a healthcare professional.

GNH USA supplies Lamisil as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamisil is an allylamine antifungal indicated for superficial fungal infections of the skin and nails.

- Tinea pedis: reduces fungal growth and relieves itching, scaling and redness on the feet. - Tinea corporis: clears ring‑shaped lesions by inhibiting the causative dermatophytes. - Tinea cruris: alleviates itching and erythema in the groin area. - Onychomycosis (topical treatment): improves nail appearance by limiting fungal colonisation on the nail surface.

Common Side Effects: - Itching at the application site - Burning sensation - Redness or erythema - Dryness or peeling of skin - Stinging feeling - Mild rash

Serious or Rare Side Effects: - Severe contact dermatitis - Allergic reactions such as swelling or hives - Stevens‑Johnson syndrome (very rare) - Photosensitivity reactions - Significant liver enzyme elevation (systemic absorption) - Persistent ulceration or infection at the site of application

Before using Lamisil, consider the following precautions: - Avoid use on broken or inflamed skin: apply only to intact epidermis. - Do not apply to mucous membranes: keep away from eyes, mouth and genital mucosa. - Limit exposure to sunlight: use sunscreen if treated area will be exposed. - Discontinue if severe irritation occurs: seek medical advice promptly. - Consult a physician if infection persists beyond the recommended treatment period. - Store at room temperature: keep in the original container, protect from moisture and heat.

Terbinafine topical may interact with other agents applied to the skin.

Major Interactions (Avoid): - Concurrent oral terbinafine: increased risk of systemic toxicity. - Topical corticosteroids: may reduce antifungal efficacy. - Other topical antifungals: can cause excessive irritation.

Moderate Interactions (Monitor Closely): - Alcohol‑based hand sanitizers: may increase skin dryness. - Skin care products containing acids (e.g., glycolic acid): monitor for irritation. - Phototoxic agents (e.g., psoralen): watch for enhanced photosensitivity.